No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents, Immunological / adverse effects
-
Clinical Trials as Topic
-
Humans
-
Incidence
-
Molecular Targeted Therapy
-
Neoplasms / drug therapy*
-
Nivolumab / adverse effects
-
Photosensitivity Disorders / epidemiology*
-
Piperidines / adverse effects
-
Quinazolines / adverse effects
-
Risk Assessment
-
Vemurafenib / adverse effects
Substances
-
Antineoplastic Agents
-
Antineoplastic Agents, Immunological
-
Piperidines
-
Quinazolines
-
Vemurafenib
-
Nivolumab
-
vandetanib